Skadden is representing AbbVie Inc., a New York Stock Exchange-listed, Illinois-based pharmaceutical company, on corporate finance, banking and tax aspects of its recommended $55 billion combination with London Stock Exchange-listed pharmaceutical group Shire plc.


www.skadden.com